Interações medicamentosas
Denosumab + Rozanolixizumab
Gravidade: Moderada
Denosumab and Rozanolixizumab: moderate interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Rozanolixizumab blocks the neonatal Fc receptor, reducing IgG recycling and shortening IgG half-life. Denosumab is an IgG2 antibody, so its exposure and antiresorptive effect could theoretically be reduced. Clinical data are lacking.
O que esta interação significa em palavras simples
Denosumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Denosumab belongs to Oncology; Rozanolixizumab belongs to Miscellaneous.
Por que acontece
FcRn blockade accelerates IgG catabolism and may lower denosumab concentrations.
O que fazer
Monitor bone turnover markers and bone density for loss of effect. Consider alternative non-antibody antiresorptive therapy if denosumab is needed long term.
O que perguntar ao farmacêutico
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Denosumab e Rozanolixizumab, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 14 dias na web. Sem cartão.
Outras interações de Denosumab
- Abatacept + Denosumab Moderada
- Adalimumab + Denosumab Moderada
- Alefacept + Denosumab Moderada
- Alemtuzumab + Denosumab Moderada
- Anakinra + Denosumab Moderada
- Azacitidine + Denosumab Moderada
Outras interações de Rozanolixizumab
- Rozanolixizumab + Upadacitinib Grave
- Abatacept + Rozanolixizumab Moderada
- Adalimumab + Rozanolixizumab Moderada
- Ado-trastuzumab + Rozanolixizumab Moderada
- Basiliximab + Rozanolixizumab Moderada
- Bevacizumab + Rozanolixizumab Moderada
Perguntas frequentes
Can I take Denosumab with Rozanolixizumab?
MediHelp rates the interaction as moderate. Denosumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rozanolixizumab blocks the neonatal Fc receptor, reducing IgG recycling and shortening IgG half-life. Denosumab is an IgG2 antibody, so its exposure and antiresorptive effect could theoretically be reduced. Clinical data are lacking.
How serious is the interaction between Denosumab and Rozanolixizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor bone turnover markers and bone density for loss of effect. Consider alternative non-antibody antiresorptive therapy if denosumab is needed long term.
What other medicines interact with Denosumab?
MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
